# Formulation Comparison in Normal Volunteers

> **NCT01250197** · PHASE1 · COMPLETED · sponsor: **Aerie Pharmaceuticals** · enrollment: 18 (estimated)

## Conditions studied

- Normal Volunteers

## Interventions

- **DRUG:** AR-12286

## Key facts

- **NCT ID:** NCT01250197
- **Lead sponsor:** Aerie Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2010-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250197, "Formulation Comparison in Normal Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01250197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*